Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Vascular ; 31(2): 379-386, 2023 Apr.
Article in English | MEDLINE | ID: mdl-35238256

ABSTRACT

INTRODUCTION: Approximately 5000 major lower-limb amputations (MLLA) for PAD occur per-annum in the UK with clinical outcomes being poor for this high-risk cohort of patients. Existing evidence suggests that anaemic surgical patients have an increased 30-day mortality, but this has not been explored in the context of MLLA. Recent prioritization processes suggested that MLLAs are a target area for research into outcome improvement. This cohort study evaluates the impact of anaemia on the outcome of MLLA to understand if optimization might improve outcomes. METHODS: All PAD patients undergoing MLLA during 2015-2018 at a tertiary vascular centre were reviewed. Patients were stratified into groups; non-anaemia (>12 g/dL), mild-anaemia (12-10 g/dL) and severe-anaemia (<10 g/dL) by pre-operative haemoglobin (Hb). Primary outcome was overall survival by Kaplan-Meier. Secondary outcomes included length of stay (LOS), post-operative blood-transfusion, surgical-site infection (SSI) and myocardial infarction (MI). Cox-proportional-hazard and receiver-operator characteristics (ROC) analyses were conducted. RESULTS: 345 patients were followed up over (mean) 23 months. 105 were non-anaemic, 111 mildly anaemic and 129 severely anaemic. Patients with severe-anaemia had a higher incidence of heart and renal failure (p = 0.003) than those with non- or mild-anaemia. Overall survival worsened significantly with increasing anaemia (p = 0.001). LOS was significantly longer in mild-anaemia which is 26 (16-43) days, (p = 0.006) and severe-anaemia of 28 days (17-40), (p < 0.001) compared to non-anaemia of 18 (10-30) days. Post-operative blood-transfusion (RBC) was required more frequently in 70.5% of severely anaemic patients (p < 0.001), compared to mildly anaemic (24.3%) and non-anaemic (7.6%) patients, with those receiving RBCs having a significantly worse survival. There was no difference in MI, SSI or wound dehiscence. Anaemia was significantly associated with mortality; (HR 1.7 (1.04-2.78), p = 0.03). A minimum-Hb of 10.4 g/L (by ROC) was identified as a cutoff Hb for an increased risk of mortality. CONCLUSION: Pre-operative anaemia is associated with worse outcome following MLLA, with increasing severity of anaemia associated with increasing mortality and RBC transfusion being potentially detrimental. More work is required to prospectively evaluate this relationship in this complex and multi-morbid cohort of patients.


Subject(s)
Anemia , Myocardial Infarction , Humans , Cohort Studies , Anemia/complications , Anemia/diagnosis , Hemoglobins , Amputation, Surgical/adverse effects , Lower Extremity
2.
Vascular ; 30(4): 698-707, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34120534

ABSTRACT

INTRODUCTION: Acute limb ischaemia (ALI) forms a significant part of the vascular surgery workload and carries with it high rates of morbidity and mortality. Anaemia is also common amongst vascular surgical patients and has been linked with poor outcomes in some subgroups. We aimed to assess the frequency of anaemia in patients with ALI and its impact on survival and complications following revascularisation to help direct future efforts to optimise outcomes in this patient group. METHODS: A retrospective analysis of prospectively collected departmental data on patients undergoing surgical intervention for ALI between 2014 and 2018 was performed. Anaemia was defined as a pre-operative haemoglobin (Hb) of <120 g/L for women and <130 g/L for men. The primary outcome was overall survival, assessed with the Kaplan-Meier estimator, with application of Cox proportional hazard modelling to adjust for confounding covariates. RESULTS: There were 158 patients who underwent treatment for ALI: 89 (56.3%) of these were non-anaemic with a mean Hb of 146 (SD = 18.4), and 69 (43.7%) were anaemic with a mean Hb of 106 (SD = 13.4). Anaemic patients had a significantly higher risk of death than their non-anaemic counterparts on univariate analysis (HR = 2.11, 95% CIs, 1.28-3.5, p = 0.0036). There was ongoing divergence in survival up to around 6 months between anaemic and non-anaemic groups. Under the Cox model, anaemia was similarly significant as a predictor of death (HR = 2.15, 95% CIs, 1.17-3.95, p = 0.013), accounting for recorded comorbidities, medication use and blood transfusion. CONCLUSIONS: Anaemia is a significant and independent risk factor for death following revascularisation for ALI and can be potentially be modified. Vascular surgical centres should ensure they have robust pathways in place to identify and consider treating anaemia. There is scope for further work to assess how to best optimise a patient's levels of circulating haemoglobin.


Subject(s)
Anemia , Peripheral Vascular Diseases , Anemia/complications , Anemia/diagnosis , Female , Hemoglobins/metabolism , Humans , Ischemia/complications , Ischemia/diagnosis , Ischemia/surgery , Male , Retrospective Studies , Risk Factors
3.
Ann Vasc Surg ; 75: 227-236, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33819585

ABSTRACT

BACKGROUND: Sarcopenia is adversely associated with survival in several diseases. Vasculopathy is often associated with multimorbidity and consequent deconditioning with poor long-term outcomes. This study examined the impact of sarcopenia on clinical outcome in patients with and without critical limb-threatening ischaemia who underwent infrainguinal bypass surgery. METHODS: All patients undergoing infra-inguinal surgical revascularisation in 2016-2018 were retrospectively reviewed. Sarcopenia was defined as a skeletal muscle area at the L3 vertebral level (defined as L3 muscle area < 114cm2 for men or <89.8cm2 for women) on CT angiography. The primary outcome was overall survival by analysed by time to event analysis. Secondary outcomes included ipsilateral major lower-limb amputation, length of hospital stay, myocardial infarction and surgical-site infection. RESULTS: A total of 116 patients with a mean age of 66.9 years were included, with a mean follow-up of 21 months. 14 (12%) of patients were sarcopenic; there were more patients with diabetes (40% vs 7%) in the sarcopenic group, p=0.018. Age, gender, Rutherford grade at presentation, other co-morbidities, other laboratory tests, conduit material and Rutherford grade at presentation were similar in those with and without sarcopenia and were statistically insignificant upon testing. Overall survival was worse for sarcopenic patients (Log Rank P=0.001) and Hazard Ratio for death 5.8; 95%CI 1.8-19.1; P=0.001. Major lower-limb amputation occurred more frequently in patients with sarcopenia (7/14 [50%] vs 23/102 [23%]; P=0.046). There was no difference in other secondary outcomes including rates of graft occlusion, myocardial infarction, surgical site infection and length of stay. Adding SMA measurement to a multivariate generalised linear model including age, sex, diabetes, and haemoglobin improved the AUROC from 0.75-0.85. CONCLUSION: In this cohort of patients undergoing vascular surgery, sarcopenia defined using L3 muscle area was significantly associated with overall mortality and major lower-limb amputation.


Subject(s)
Amputation, Surgical/adverse effects , Ischemia/surgery , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Sarcopenia/complications , Vascular Grafting/adverse effects , Aged , Amputation, Surgical/mortality , Critical Illness , Databases, Factual , Female , Humans , Ischemia/complications , Ischemia/diagnostic imaging , Ischemia/mortality , Limb Salvage , Male , Middle Aged , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/diagnostic imaging , Peripheral Arterial Disease/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Sarcopenia/diagnostic imaging , Sarcopenia/mortality , Time Factors , Treatment Outcome , Vascular Grafting/mortality
4.
Angiology ; 72(5): 474-479, 2021 May.
Article in English | MEDLINE | ID: mdl-33401955

ABSTRACT

The Edinburgh Claudication Questionnaire (ECQ) was developed to help identify peripheral arterial disease (PAD) in the general population but has not been validated against diagnostic arterial imaging methods such as Duplex Vascular Ultrasound Scanning (DUS). In the present study, we assessed the accuracy of the ECQ for diagnosis using DUS. As part of a National Institute of Health Research funded project looking at novel diagnostic methods, 250 patients were studied from 15 general practices across North East England from May 2015 and November 2016. Practices identified those with a PAD diagnosis from their registers as well as age- and sex-matched controls. All the ECQs were recorded by a vascular specialist nurse. Duplex vascular ultrasound scanning was used as a reference standard for the diagnosis of occlusive PAD. The ECQ had a sensitivity of 52.5% (95% CI: 42.3%-62.5%), specificity of 87.1% (95% CI: 80.6%-92.0%), positive likelihood ratio of 4.06 (95% CI: 2.57-6.42), and negative likelihood ratio of 0.55 (95% CI: 0.44-0.68) compared with reference standard DUS. The ECQ has relatively poor overall diagnostic test accuracy in isolation. It may be helpful in ruling out PAD or as a supplementary test to improve diagnosis of symptomatic disease in General Practice.


Subject(s)
General Practice , Intermittent Claudication/diagnosis , Peripheral Arterial Disease/diagnosis , Primary Health Care , Surveys and Questionnaires , Aged , Aged, 80 and over , Case-Control Studies , England , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Reproducibility of Results , Ultrasonography, Doppler, Duplex
5.
J Prim Care Community Health ; 11: 2150132720946148, 2020.
Article in English | MEDLINE | ID: mdl-32959726

ABSTRACT

BACKGROUND: Approximately 20% of the UK population aged 55 to 75 years have evidence of peripheral arterial disease (PAD). PAD affects quality of life and life expectancy if not appropriately diagnosed and managed. At risk patients require accurate diagnosis to ensure optimal treatment to slow disease progression and minimize adverse outcomes. AIM: To assess the accuracy of general practice (GP) registration of the diagnosis of peripheral arterial disease (PAD). DESIGN AND SETTING: An observational analytic case-control study. As part of a National Institute for Health Research-funded (ISRCTN13301188) project assessing novel diagnostic methods set in GP practice. METHODS: A total of 125 patients registered as having PAD and 125 age- and sex-matched controls were recruited from 15 general practices across North East England. The register was then assessed for accuracy of diagnosis. Duplex vascular ultrasound scanning (DUS) undertaken by vascular scientists was used as the gold standard reference for PAD. RESULTS: The PAD register had a sensitivity of 86% (95% CI 77%-92%) and specificity of 74% (95% CI 67%-81%) when compared with DUS. The positive predictive value, however, was 69.6% (95% CI 63%-75%) and negative predictive value 88.8% (95% CI 82%-92%). The overall diagnostic effectiveness of the PAD register was 79.2% (95% CI 73%-84%). CONCLUSION: This analysis indicates that while PAD is detected with reasonable sensitivity in primary care, many patients registered with a diagnosis of PAD lacked DUS-proven disease. Improved approaches to the objective diagnosis of PAD may improve diagnosis and management of PAD in primary care.


Subject(s)
General Practice , Peripheral Arterial Disease , Case-Control Studies , England , Humans , Peripheral Arterial Disease/diagnosis , Peripheral Arterial Disease/epidemiology , Quality of Life , United Kingdom/epidemiology
6.
Ann Vasc Surg ; 66: 586-594, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31863946

ABSTRACT

BACKGROUND: Anemia is associated with greater mortality and complications in cardiovascular surgery. Within chronic limb-threatening ischemia, the effect of anemia is becoming apparent. This study aimed to further understand the influence of anemia in patients undergoing surgical revascularization for lower limb ischemia. METHODS: A retrospective review of all patients undergoing infrainguinal surgical revascularization between 2016 and 2018 at a tertiary center was performed. Anemia was defined as an hemoglobin (Hb) level of less than 120 g/L. The primary outcome was overall survival by the Kaplan-Meier analysis. Secondary outcomes included length of hospital stay, blood transfusion requirements, wound infection, myocardial infarction, and limb-loss and all-cause mortality. The Cox proportional-hazard analysis and receiver operating characteristics (ROC) were performed. RESULTS: A total of 124 patients were followed-up for a mean of 23(8) months. Forty-five patients were anemic. There were comparable baseline demographics, comorbidity, and severity of symptoms. Overall survival was significantly worse (logrank P < 0.01) in the anemic group as was the duration of stay, 27 (23) days vs. 14 (16) days (P = 0.001). Patients with anemia received more blood transfusions, 19 (42%) compared with 13 (16.5%) (P = 0.001), and had more cardiac complications (11.1% vs. 3.8%) (P = 0.02). Surgical site infection rates were also higher (20% vs. 6.3%; P = 0.036). There was no difference in graft patency or subsequent ipsilateral major lower extremity amputation. Thirty-day mortality was comparable between the anemic versus the nonanaemic groups, 3 (6.7%) vs. 1 (1.3%) (P = 0.132). At 1 year, there was a higher mortality rate in the anemic group of 8 (18%) vs. 4 (5%) in the nonanaemic group (P = 0.037), which persisted to the long term. Anemia was independently associated with mortality; hazard ratio 4.0 (1.14-12.1). A 'cut-off' Hb level of 112 g/L was identified by ROC analysis. CONCLUSIONS: Preoperative anemia in infrainguinal bypass surgery has a significant association with mortality and morbidity. Preoperative anemia should prompt the vascular team to consider these patients as high risk and consider optimization of Hb.


Subject(s)
Anemia/complications , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Vascular Grafting , Aged , Amputation, Surgical , Anemia/blood , Anemia/mortality , Biomarkers/blood , Blood Transfusion , Databases, Factual , Female , Hemoglobins/metabolism , Humans , Length of Stay , Limb Salvage , Male , Middle Aged , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/mortality , Postoperative Complications/mortality , Postoperative Complications/therapy , Retrospective Studies , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome , Vascular Grafting/adverse effects , Vascular Grafting/mortality
8.
Int J Cardiol ; 224: 256-264, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27664572

ABSTRACT

The pattern and global burden of disease has evolved considerably over the last two decades, from primarily communicable, maternal, and perinatal causes to non-communicable disease (NCD). Cardiovascular disease (CVD) has become the single most important and largest cause of NCD deaths worldwide at over 50%. The World Health Organisation (WHO) estimates that 17.6 million people died of CVD worldwide in 2012. Proportionally, this accounts for an estimated 31.43% of global mortality, with ischaemic heart disease (IHD) accounting for approximately 7.4 million deaths, 13.2% of the total. IHD was also the greatest single cause of death in 2000, accounting for an estimated 6.0 million deaths. The global burden of CVD falls, principally, on the low and middle-income (LMI) countries, accounting for over 80% of CVD deaths. Individual populations face differing challenges and each population has unique health burdens, however, CVD remains one of the greatest health challenges both nationally and worldwide.


Subject(s)
Cardiovascular Diseases/mortality , Global Health/trends , Statistics as Topic/trends , World Health Organization , Cardiovascular Diseases/diagnosis , Cause of Death/trends , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...